With current guidelines generally advising against routine ultrasound screening for thyroid nodules in the general population, a combined predictive approach using IGF-1, IGFBP-3, and the IGF-1/IGFBP-3 ratio might hold promise for preventing thyroid nodules in T2DM patients. The gene discussed is IGFBP3; the disease is type 2 diabetes mellitus.